Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins

Progress in Lipid Research

Volumn 43, Issue 4, 2004, Pages 350-380

  Saito, Hiroyuki ^a   Lund Katz, Sissel ^a   Phillips, Michael C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

ABCA1, ATP binding cassette transporter A1; ANS, 8 anilino 1 naphthalenesulfonic acid; apo, apolipoprotein; CD, circular dichroism; CE, cholesteryl ester; DMPC, 1,2 dimyristoyl phosphatidylcholine; FRET, fluorescence resonance energy transfer

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN C; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ARGININE; CHOLESTEROL ACYLTRANSFERASE; CHYLOMICRON; CYSTEINE; GLUTAMIC ACID; HIGH DENSITY LIPOPROTEIN; LYSINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VERY LOW DENSITY LIPOPROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL TRANSPORT; CRYSTAL STRUCTURE; ENDOCYTOSIS; ENZYME ACTIVITY; EXON; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; FOOD INTAKE; GASTROINTESTINAL MOTILITY; LIPID OXIDATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; REVIEW; SITE DIRECTED MUTAGENESIS; TANDEM REPEAT; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS C; APOLIPOPROTEINS E; HUMANS; LIPID METABOLISM; MODELS, CHEMICAL; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3242656580     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2004.05.002     Document Type: Review

References (170)

1. Li W.H., Tanimura M., Luo C.C., Datta S., Chan L. The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. J. Lipid Res. 29:1988;245-271
2. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Schumaker V.N. Adv. Protein Chem. 1994;249-302 Academic Press, London
3. Brouillette C.G., Anantharamaiah G.M. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256:1995;103-129
4. Brouillette C.G., Anantharamaiah G.M., Engler J.A., Borhani D.W. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim. Biophys. Acta. 1531:2001;4-46
5. Frank P.G., Marcel Y.L. Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 41:2000;853-872
6. Narayanaswami V., Ryan R.O. Molecular basis of exchangeable apolipoprotein function. Biochim. Biophys. Acta. 1483:2000;15-36
7. Bolanos-Garcia V.M., Miguel R.N. On the structure and function of apolipoproteins: more than a family of lipid-binding proteins. Prog. Biophys. Mol. Biol. 83:2003;47-68
8. Segrest J.P., Jones M.K., De Loof H., Brouillette C.G., Venkatachalapathi Y.V., Anantharamaiah G.M. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33:1992;141-166
9. Nolte R.T., Atkinson D. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys. J. 63:1992;1221-1239
10. Segrest J.P., De Loof H., Dohlman J.G., Brouillette C.G., Anantharamaiah G.M. Amphipathic helix motif: classes and properties. Proteins. 8:1990;103-117
11. Segrest J.P., Garber D.W., Brouillette C.G., Harvey S.C., Anantharamaiah G.M. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Protein Chem. 45:1994;303-369
12. Mishra V.K., Palgunachari M.N. Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes. Biochemistry. 35:1996;11210-11220
13. Collet X., Marcel Y.L., Tremblay N., Lazure C., Milne R.W., Perret B., et al. Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure. J. Lipid Res. 38:1997;634-644
14. Palgunachari M.N., Mishra V.K., Lund-Katz S., Phillips M.C., Adeyeye S.O., Alluri S., et al. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler. Thromb. Vasc. Biol. 16:1996;328-338
15. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132
16. Gorshkova I.N., Liadaki K., Gursky O., Atkinson D., Zannis V.I. Probing the lipid-free structure and stability of apolipoprotein A-I by mutation. Biochemistry. 39:2000;15910-15919
17. Oda M.N., Forte T.M., Ryan R.O., Voss J.C. The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger. Nat. Struct. Biol. 10:2003;455-460
18. Mishra V.K., Palgunachari M.N., Datta G., Phillips M.C., Lund-Katz S., Adeyeye S.O., et al. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic α-helixes. Biochemistry. 37:1998;10313-10324
19. Fang Y., Gursky O., Atkinson D. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants. Biochemistry. 42:2003;13260-13268
20. Mahley R.W., Innerarity T.L., Rall S.C. Jr., Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25:1984;1277-1294
21. Weisgraber K.H., Rall S.C. Jr., Mahley R.W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256:1981;9077-9083
22. Wetterau J.R., Aggerbeck L.P., Rall S.C. Jr., Weisgraber K.H. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263:1988;6240-6248
23. Aggerbeck L.P., Wetterau J.R., Weisgraber K.H., Wu C.S., Lindgren F.T. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J. Biol. Chem. 263:1988;6249-6258
24. Wilson C., Wardell M.R., Weisgraber K.H., Mahley R.W., Agard D.A. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 252:1991;1817-1822
25. Breiter D.R., Kanost M.R., Benning M.M., Wesenberg G., Law J.H., Wells M.A., et al. Molecular structure of an apolipoprotein determined at 2.5-Å resolution. Biochemistry. 30:1991;603-608
26. Wilson C., Mau T., Weisgraber K.H., Wardell M.R., Mahley R.W., Agard D.A. Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure. 2:1994;713-718
27. Dong L.M., Parkin S., Trakhanov S.D., Rupp B., Simmons T., Arnold K.S., et al. Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat. Struct. Biol. 3:1996;718-722
28. Dong L.M., Wilson C., Wardell M.R., Simmons T., Mahley R.W., Weisgraber K.H., et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269:1994;22358-22365
29. Morrow J.A., Segall M.L., Lund-Katz S., Phillips M.C., Knapp M., Rupp B., et al. Differences in stability among the human apolipoprotein E isoforms determined by theamino-terminal domain. Biochemistry. 39:2000;11657-11666
30. Acharya P., Segall M.L., Zaiou M., Morrow J., Weisgraber K.H., Phillips M.C., et al. Comparison of the stabilities and unfolding pathways of human apolipoprotein Eisoforms by differential scanning calorimetry and circular dichroism. Biochim. Biophys. Acta. 1584:2002;9-19
31. Saito H., Dhanasekaran P., Baldwin F., Weisgraber K.H., Phillips M.C., Lund-Katz S. Effects of polymorphism on the lipid interaction of human apolipoprotein e. J. Biol. Chem. 278:2003;40723-40729
32. Choy N., Raussens V., Narayanaswami V. Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain. J. Mol. Biol. 334:2003;527-539
33. Roberts L.M., Ray M.J., Shih T.W., Hayden E., Reader M.M., Brouillette C.G. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I. Biochemistry. 36:1997;7615-7624
34. Davidson W.S., Hazlett T., Mantulin W.W., Jonas A. The role of apolipoprotein AI domains in lipid binding. Proc. Natl. Acad. Sci. USA. 93:1996;13605-13610
35. Saito H., Dhanasekaran P., Nguyen D., Holvoet P., Lund-Katz S., Phillips M.C. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model. J. Biol. Chem. 278:2003;23227-23232
36. Davidson W.S., Arnvig-McGuire K., Kennedy A., Kosman J., Hazlett T.L., Jonas A. Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants. Biochemistry. 38:1999;14387-14395
37. Kiss R.S., Kay C.M., Ryan R.O. Amphipathic α-helix bundle organization of lipid-free chicken apolipoprotein A-I. Biochemistry. 38:1999;4327-4334
38. Borhani D.W., Rogers D.P., Engler J.A., Brouillette C.G. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:1997;12291-12296
39. Reijngoud D.J., Phillips M.C. Mechanism of dissociation of human apolipoprotein A-I from complexes with dimyristoylphosphatidylcholine as studied by guanidine hydrochloride denaturation. Biochemistry. 21:1982;2969-2976
40. Gursky O., Atkinson D. Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc. Natl. Acad. Sci. USA. 93:1996;2991-2995
41. Wang J., Sykes B.D., Ryan R.O. Structural basis for the conformational adaptability of apolipophorin III, a helix-bundle exchangeable apolipoprotein. Proc. Natl. Acad. Sci. USA. 99:2002;1188-1193
42. Tricerri M.A., Behling Agree A.K., Sanchez S.A., Jonas A. Characterization of apolipoprotein A-I structure using a cysteine-specific fluorescence probe. Biochemistry. 39:2000;14682-14691
43. Behling Agree A.K., Tricerri M.A., Arnvig McGuire K., Tian S.M., Jonas A. Folding and stability of the C-terminal half of apolipoprotein A-I examined with a Cys-specific fluorescence probe. Biochim. Biophys. Acta. 1594:2002;286-296
44. Fang Y., Gursky O., Atkinson D. Structural studies of N- and C-terminally truncated human apolipoprotein A-I. Biochemistry. 42:2003;6881-6890
45. Weisgraber K.H. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31:1990;1503-1511
46. Dong L.M., Weisgraber K.H. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271:1996;19053-19057
47. Mahley R.W., Huang Y., Rall S.C. Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J. Lipid Res. 40:1999;1933-1949
48. Narayanaswami V., Szeto S.S., Ryan R.O. Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3. J. Biol. Chem. 276:2001;37853-37860
49. Vitello L.B., Scanu A.M. Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions. J. Biol. Chem. 251:1976;1131-1136
50. Yokoyama S., Kawai Y., Tajima S., Yamamoto A. Behavior of human apolipoprotein E in aqueous solutions and at interfaces. J. Biol. Chem. 260:1985;16375-16382
51. Westerlund J.A., Weisgraber K.H. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268:1993;15745-15750
52. Perugini M.A., Schuck P., Howlett G.J. Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid. J. Biol. Chem. 275:2000;36758-36765
53. Ji Y., Jonas A. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270:1995;11290-11297
54. Holvoet P., Zhao Z., Vanloo B., Vos R., Deridder E., Dhoest A., et al. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry. 34:1995;13334-13342
55. Weisgraber K.H., Lund-Katz S., Phillips M.C. Apolipoprotein E: structure-function correlations. Mill N.E., Tall A.R. High density lipoproteins and atherosclerosis III. 1992;175-181 Elsevier, Amsterdam
56. Raussens V., Fisher C.A., Goormaghtigh E., Ryan R.O., Ruysschaert J.M. The low density lipoprotein receptor active conformation of apolipoprotein E. Helix organization in n-terminal domain-phospholipid disc particles. J. Biol. Chem. 273:1998;25825-25830
57. Fisher C.A., Ryan R.O. Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. J. Lipid Res. 40:1999;93-99
58. Lu B., Morrow J.A., Weisgraber K.H. Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid. J. Biol. Chem. 275:2000;20775-20781
59. Segall M.L., Dhanasekaran P., Baldwin F., Anantharamaiah G.M., Weisgraber K.H., Phillips M.C., et al. Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization. J. Lipid Res. 43:2002;1688-1700
60. Weers P.M., Narayanaswami V., Choy N., Luty R., Hicks L., Kay C.M., et al. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability. Biophys. Chem. 100:2003;481-492
61. Morrow J.A., Hatters D.M., Lu B., Hochtl P., Oberg K.A., Rupp B., et al. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J. Biol. Chem. 277:2002;50380-50385
62. Pownall H.J., Massey J.B., Kusserow S.K., Gotto A.M. Jr. Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry. 17:1978;1183-1188
63. Rogers D.P., Roberts L.M., Lebowitz J., Datta G., Anantharamaiah G.M., Engler J.A., et al. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37:1998;11714-11725
64. Gorshkova I.N., Liu T., Zannis V.I., Atkinson D. Lipid-free structure and stability of apolipoprotein A-I: probing the central region by mutation. Biochemistry. 41:2002;10529-10539
65. Okon M., Frank P.G., Marcel Y.L., Cushley R.J. Heteronuclear NMR studies of human serum apolipoprotein A-I. Part I. Secondary structure in lipid-mimetic solution. FEBS Lett. 517:2002;139-143
66. Saito H., Dhanasekaran P., Nguyen D., Deridder E., Holvoet P., Lund-Katz S., et al. α-Helix formation is required for high affinity binding of human apolipoprotein A-I to lipids. J. Biol. Chem. 279:2004;20974-20981
67. Massey J.B., Gotto A.M. Jr., Pownall H.J. Contribution of α helix formation in human plasma apolipoproteins to their enthalpy of association with phospholipids. J. 254:1979;9559-9561
68. Tricerri M.A., Sanchez S.A., Arnulphi C., Durbin D.M., Gratton E., Jonas A. Interaction of apolipoprotein A-I in three different conformations with palmitoyl oleoyl phosphatidylcholine vesicles. J. Lipid Res. 43:2002;187-197
69. Derksen A., Gantz D., Small D.M. Calorimetry of apolipoprotein-A1 binding to phosphatidylcholine-triolein-cholesterol emulsions. Biophys. J. 70:1996;330-338
70. Saito H., Dhanasekaran P., Baldwin F., Weisgraber K.H., Lund-Katz S., Phillips M.C. Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles. J. Biol. Chem. 276:2001;40949-40954
71. Gazzara J.A., Phillips M.C., Lund-Katz S., Palgunachari M.N., Segrest J.P., Anantharamaiah G.M., et al. Interaction of class A amphipathic helical peptides with phospholipid unilamellar vesicles. J. Lipid Res. 38:1997;2134-2146
72. Lund-Katz S., Liu L., Thuahnai S.T., Phillips M.C. High density lipoprotein structure. Front. Biosci. 8:2003;d1044-1054
73. Phillips J.C., Wriggers W., Li Z., Jonas A., Schulten K. Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. Biophys. J. 73:1997;2337-2346
74. Klon A.E., Segrest J.P., Harvey S.C. Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles. Biochemistry. 41:2002;10895-10905
75. Koppaka V., Silvestro L., Engler J.A., Brouillette C.G., Axelsen P.H. The structure of human lipoprotein A-I. Evidence for the "belt model. J. Biol. Chem. 274:1999;14541-14544
76. Maiorano J.N., Davidson W.S. The orientation of helix 4 in apolipoprotein A-I-containing reconstituted high density lipoproteins. J. Biol. Chem. 275:2000;17374-17380
77. Panagotopulos S.E., Horace E.M., Maiorano J.N., Davidson W.S. Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins. J. Biol. Chem. 276:2001;42965-42970
78. Li H., Lyles D.S., Thomas M.J., Pan W., Sorci-Thomas M.G. Structural determination of lipid-bound ApoA-I using fluorescence resonance energy transfer. J. Biol. Chem. 275:2000;37048-37054
79. Segrest J.P., Jones M.K., Klon A.E., Sheldahl C.J., Hellinger M., De Loof H., et al. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J. Biol. Chem. 274:1999;31755-31758
80. Tricerri M.A., Behling Agree A.K., Sanchez S.A., Bronski J., Jonas A. Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: an alternative model based on fluorescence resonance energy transfer experiments. Biochemistry. 40:2001;5065-5074
81. Davidson W.S., Hilliard G.M. The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass specrometry study. J. Biol. Chem. 278:2003;27199-27207
82. De Pauw M., Vanloo B., Weisgraber K., Rosseneu M. Comparison of lipid-binding and lecithin:cholesterol acyltransferase activation of the amino- and carboxyl-terminal domains of human apolipoprotein E3. Biochemistry. 34:1995;10953-10966
83. Fisher C.A., Narayanaswami V., Ryan R.O. The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E. J. Biol. Chem. 275:2000;33601-33606
84. Narayanaswami V., Maiorano J.N., Dhanasekaran P., Ryan R.O., Phillips M.C., Lund-Katz S., et al. Helix orientation of the functional domains in apolipoprotein E in discoidal high density lipoprotein particles. J. Biol. Chem. 279:2004;14273-14279
85. Curtiss L.K., Bonnet D.J., Rye K.A. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry. 39:2000;5712-5721
86. 13C NMR studies of lysine ionization behavior. J. Biol. Chem. 267:1992;25830-25838
87. Wang L., Atkinson D., Small D.M. Interfacial properties of an amphipathic α-helix consensus peptide of exchangeable apolipoproteins at air/water and oil/water interfaces. J. Biol. Chem. 278:2003;37480-37491
88. Corsico B., Toledo J.D., Garda H.A. Evidence for a central apolipoprotein A-I domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles. J. Biol. Chem. 276:2001;16978-16985
89. Li H.H., Lyles D.S., Pan W., Alexander E., Thomas M.J., Sorci-Thomas M.G. ApoA-I structure on discs and spheres. Variable helix registry and conformational states. J. Biol. Chem. 277:2002;39093-39101
90. Blanco-Vaca F., Escola-Gil J.C., Martin-Campos J.M., Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J. Lipid Res. 42:2001;1727-1739
91. Brewer H.B., Jr S.E., Lux R., Ronan K.M. Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. Proc. Natl. Acad. Sci. USA. 69:1972;1304-1308
92. Kumar M.S., Carson M., Hussain M.M., Murthy H.M. Structures of apolipoprotein A-II and a lipid-surrogate complex provide insights into apolipoprotein-lipid interactions. Biochemistry. 41:2002;11681-11691
93. Gursky O., Atkinson D. High- and low-temperature unfolding of human high-density apolipoprotein A-2. Protein Sci. 5:1996;1874-1882
94. Ibdah J.A., Krebs K.E., Phillips M.C. The surface properties of apolipoproteins A-I and A-II at the lipid/water interface. Biochim. Biophys. Acta. 1004:1989;300-308
95. Lagocki P.A., Scanu A.M. In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II. J. Biol. Chem. 255:1980;3701-3706
96. van Tornout P., Caster H., Lievens M.J., Rosseneu M., Assmann G. In vitro interaction of human HDL with human apolipoprotein A-II. Synthesis of apolipoprotein A-II-rich HDL. Biochim. Biophys. Acta. 663:1981;630-636
97. Rye K.A. Interaction of apolipoprotein A-II with recombinant HDL containing egg phosphatidylcholine, unesterified cholesterol and apolipoprotein A-I. Biochim. Biophys. Acta. 1042:1990;227-236
98. Rye K.A., Barter P.J. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. J. Biol. Chem. 269:1994;10298-10303
99. Pownall H.J., Hickson D., Gotto A.M. Jr. Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein. J. Biol. Chem. 256:1981;9849-9854
100. Lund-Katz S., Murley Y.M., Yon E., Gillotte K.L., Davidson W.S. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles. Lipids. 31:1996;1107-1113
101. Swaney J.B., Reese H., Eder H.A. Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis. Biochem. Biophys. Res. Commun. 59:1974;513-519
102. Fujimoto K., Fukagawa K., Sakata T., Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1993;1830-1833
103. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am. J. Physiol. 270:1996;G49-G53
104. Lefevre M., Roheim P.S. Metabolism of apolipoprotein A-IV. J. Lipid Res. 25:1984;1603-1610
105. Ostos M.A., Conconi M., Vergnes L., Baroukh N., Ribalta J., Girona J., et al. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:2001;1023-1028
106. Remaley A.T., Stonik J.A., Demosky S.J., Neufeld E.B., Bocharov A.V., Vishnyakova T.G., et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280:2001;818-823
107. Steinmetz A., Utermann G. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem. 260:1985;2258-2264
108. Boguski M.S., Elshourbagy N., Taylor J.M., Gordon J.I. Comparative analysis of repeated sequences in rat apolipoproteins A-I, A-IV, and E. Proc. Natl. Acad. Sci. USA. 82:1985;992-996
109. Weinberg R.B., Spector M.S. Structural properties and lipid binding of human apolipoprotein A-IV. J. Biol. Chem. 260:1985;4914-4921
110. Pearson K, Saito H, Woods SC, Lund-Katz S, Tso P, Phillips MC, et al. The structure of human apolipoprotein A-IV: a distinct domain architecture with potential functional implications; submitted
111. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294:2001;169-173
112. Talmud P.J., Hawe E., Martin S., Olivier M., Miller G.J., Rubin E.M., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11:2002;3039-3046
113. Nabika T., Nasreen S., Kobayashi S., Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis. 165:2002;201-204
114. Weinberg R.B., Cook V.R., Beckstead J.A., Martin D.D., Gallagher J.W., Shelness G.S., et al. Structure and interfacial properties of human apolipoprotein A-V. J. Biol. Chem. 278:2003;34438-34444
115. Beckstead J.A., Oda M.N., Martin D.D., Forte T.M., Bielicki J.K., Berger T., et al. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry. 42:2003;9416-9423
116. Dumon M.F., Clerc M. Preliminary report on a case of apolipoproteins CI and CII deficiency. Clin. Chim. Acta. 157:1986;239-248
117. Conde-Knape K., Bensadoun A., Sobel J.H., Cohn J.S., Shachter N.S. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase. J. Lipid Res. 43:2002;2136-2145
118. Kinnunen P.K., Ehnolm C. Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase. FEBS Lett. 65:1976;354-357
119. Gautier T., Masson D., de Barros J.P., Athias A., Gambert P., Aunis D., et al. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J. Biol. Chem. 275:2000;37504-37509
120. Kowal R.C., Herz J., Weisgraber K.H., Mahley R.W., Brown M.S., Goldstein J.L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:1990;10771-10779
121. Jackson R.L., Morrisett J.D., Sparrow J.T., Segrest J.P., Pownall H.J., Smith L.C., et al. The interaction of apolipoprotein-serine with phosphatidylcholine. J. Biol. Chem. 249:1974;5314-5320
122. Gursky O. Solution conformation of human apolipoprotein C-1 inferred from proline mutagenesis: far- and near-UV CD study. Biochemistry. 40:2001;12178-12185
123. Rozek A., Sparrow J.T., Weisgraber K.H., Cushley R.J. Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy. Biochemistry. 38:1999;14475-14484
124. Semenkovich C.F., Luo C.C., Nakanishi M.K., Chen S.H., Smith L.C., Chan L. In vitro expression and site-specific mutagenesis of the cloned human lipoprotein lipase gene. Potential N-linked glycosylation site asparagine 43 is important for both enzyme activity and secretion. J. Biol. Chem. 265:1990;5429-5433
125. MacPhee C.E., Hatters D.M., Sawyer W.H., Howlett G.J. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding. Biochemistry. 39:2000;3433-3440
126. Hatters D.M., MacPhee C.E., Lawrence L.J., Sawyer W.H., Howlett G.J. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry. 39:2000;8276-8283
127. MacRaild C.A., Hatters D.M., Howlett G.J., Gooley P.R. NMR structure of human apolipoprotein C-II in the presence of sodium dodecyl sulfate. Biochemistry. 40:2001;5414-5421
128. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12:2001;297-304
129. Lins L., Flore C., Chapelle L., Talmud P.J., Thomas A., Brasseur R. Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III. Protein Eng. 15:2002;513-520
130. Mahley R.W., Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10:1999;207-217
131. Lund-Katz S., Wehrli S., Zaiou M., Newhouse Y., Weisgraber K.H., Phillips M.C. Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. J. Lipid Res. 42:2001;894-901
132. Zaiou M., Arnold K.S., Newhouse Y.M., Innerarity T.L., Weisgraber K.H., Segall M.L., et al. Apolipoprotein E-low density lipoprotein receptor interaction: Influences of basic residue and amphipathic α-helix organization in the ligand. J. Lipid Res. 41:2000;1087-1095
133. Lund-Katz S., Zaiou M., Wehrli S., Dhanasekaran P., Baldwin F., Weisgraber K.H., et al. Effects of lipid interaction on the lysine microenvironments in apolipoprotein E. J. Biol. Chem. 275:2000;34459-34464
134. Raussens V., Slupsky C.M., Sykes B.D., Ryan R.O. Lipid-bound structure of an apolipoprotein E-derived peptide. J. Biol. Chem. 278:2003;25998-26006
135. Thuahnai S.T., Lund-Katz S., Williams D.L., Phillips M.C. Scavenger receptor class B, type I-mediated uptake of various lipids into cells. Influence of the nature of the donor particle interaction with the receptor. J. Biol. Chem. 276:2001;43801-43808
136. Thuahnai S.T., Lund-Katz S., Anantharamaiah G.M., Williams D.L., Phillips M.C. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. J. Lipid Res. 44:2003;1132-1142
137. Li X., Kan H.Y., Lavrentiadou S., Krieger M., Zannis V. Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1-165 domain of ApoE suffices for receptor binding. J. Biol. Chem. 277:2002;21149-21157
138. Gianturco S.H., Gotto A.M. Jr., Hwang S.L., Karlin J.B., Lin A.H., Prasad S.C., et al. Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J. Biol. Chem. 258:1983;4526-4533
139. Herz J., Bock H.H. Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71:2002;405-434
140. Havel R.J., Hamilton R.L. Hepatic catabolism of remnant lipoproteins: where the action is. Arterioscler. Thromb. Vasc. Biol. 24:2004;213-215
141. Burgess J.W., Gould D.R., Marcel Y.L. The HepG2 extracellular matrix contains separate heparinase- and lipid- releasable pools of ApoE. Implications for hepatic lipoprotein metabolism. J. Biol. Chem. 273:1998;5645-5654
142. Saito H., Dhanasekaran P., Nguyen D., Baldwin F., Weisgraber K.H., Wehrli S., et al. Characterization of the heparin binding sites in human apolipoprotein E. J. Biol. Chem. 278:2003;14782-14787
143. Libeu C.P., Lund-Katz S., Phillips M.C., Wehrli S., Hernaiz M.J., Capila I., et al. New insights into heparin sulfate proteoglycan-binding activity of apolipoprotein E. J. Biol. Chem. 276:2001;39138-39144
144. Zhu Y., Hui D.Y. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J. Biol. Chem. 278:2003;36257-36263
145. Swertfeger D.K., Hui D.Y. Apolipoprotein E: receptor versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation. J. Biol. Chem. 276:2001;25043-25048
146. Kothapalli D., Fuki I., Ali K., Stewart S.A., Zhao L., Yahil R., et al. Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation. J. Clin. Invest. 113:2004;609-618
147. Weisgraber K.H., Mahley R.W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1996;1485-1494
148. Pillot T., Goethals M., Najib J., Labeur C., Lins L., Chambaz J., et al. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease. J. Neurochem. 72:1999;230-237
149. Raffai R.L., Dong L.M., Farese R.V. Jr., Weisgraber K.H. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proc. Natl. Acad. Sci. USA. 98:2001;11587-11591
150. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23:2003;712-719
151. Oram J.F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 23:2003;720-727
152. Rye K.A., Barter P.J. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 24:2004;421-428
153. Chroni A., Liu T., Fitzgerald M.L., Freeman M.W., Zannis V.I. Cross-linking and lipid efflux properties of ApoA-I mutants suggest direct association between ApoA-I helices and ABCA1. Biochemistry. 43:2004;2126-2139
154. Gillotte-Taylor K., Nickel M., Johnson W.J., Francone O.L., Holvoet P., Lund-Katz S., et al. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J. Biol. Chem. 277:2002;11811-11820
155. Liu L., Bortnick A.E., Nickel M., Dhanasekaran P., Subbaiah P.V., Lund-Katz S., et al. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1- mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278:2003;42976-42984
156. Jonas A. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta. 1084:1991;205-220
157. Jonas A. Lecithin cholesterol acyltransferase. Biochim. Biophys. Acta. 1529:2000;245-256
158. Jin L., Shieh J.J., Grabbe E., Adimoolam S., Durbin D., Jonas A. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins. Biochemistry. 38:1999;15659-15665
159. Sorci-Thomas M.G., Curtiss L., Parks J.S., Thomas M.J., Kearns M.W., Landrum M. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 273:1998;11776-11782
160. Roosbeek S., Vanloo B., Duverger N., Caster H., Breyne J., De Beun I., et al. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase. J. Lipid Res. 42:2001;31-40
161. McManus D.C., Scott B.R., Frank P.G., Franklin V., Schultz J.R., Marcel Y.L. Distinct central amphipathic α-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids. J. Biol. Chem. 275:2000;5043-5051
162. Sorci-Thomas M.G., Thomas M., Curtiss L., Landrum M. Single repeat deletion in ApoA-I blocks cholesterol esterification and results in rapid catabolism of delta6 and wild-type ApoA-I in transgenic mice. J. Biol. Chem. 275:2000;12156-12163
163. Reschly E.J., Sorci-Thomas M.G., Davidson W.S., Meredith S.C., Reardon C.A., Getz G.S. Apolipoprotein A-I α-helices 7 and 8 modulate high density lipoprotein subclass distribution. J. Biol. Chem. 277:2002;9645-9654
164. Rigotti A., Miettinen H.E., Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24:2003;357-387
165. Williams D.L., Connelly M.A., Temel R.E., Swarnakar S., Phillips M.C., de la Llera-Moya M., et al. Scavenger receptor BI and cholesterol trafficking. Curr. Opin. Lipidol. 10:1999;329-339
166. Williams D.L., de La Llera-Moya M., Thuahnai S.T., Lund-Katz S., Connelly M.A., Azhar S., et al. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic α-helix as a recognition motif. J. Biol. Chem. 275:2000;18897-18904
167. de Beer M.C., Durbin D.M., Cai L., Jonas A., de Beer F.C., van der Westhuyzen D.R. Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J. Lipid Res. 42:2001;309-313
168. Thuahnai S.T., Lund-Katz S., Dhanasekaran P., De La Llera-Moya M., Connelly M.A., Williams D.L., et al. SR-BI-mediated cholesteryl ester selective uptake and efflux of unesterified cholesterol: influence of HDL size and structure. J. Biol. Chem. 2004;12448-12455
169. Gillotte K.L., Davidson W.S., Lund-Katz S., Rothblat G.H., Phillips M.C. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux. J. Biol. Chem. 271:1996;23792-23798
170. Andreola A., Bellotti V., Giorgetti S., Mangione P., Obici L., Stoppini M., et al. Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein A-I. J. Biol. Chem. 278:2003;2444-2451